|
[1]CAREY EJ, ALI AH, LINDOR KD.Primary biliary cirrhosis[J].Lancet, 2015, 386 (10003) :1565-1575.
|
|
[2]SELMI C, BOWLUS CL, GERSHWIN ME, et al.Primary biliary cirrhosis[J].Lancet, 2011, 377 (9777) :1600-1609.
|
|
[3]GULAMHUSEIN AF, HIRSCHFIELD GM.Pathophysiology of primary biliary cholangitis[J].Best Pract Res Clin Gastroenterol, 2018, 34-35:17-25.
|
|
[4]TANAKA A, LEUNG PSC, GERSHWIN ME.The genetics and epigenetics of primary biliary cholangitis[J].Clin Liver Dis, 2018, 22 (3) :443-455.
|
|
[5]GULAMHUSEIN AF, LAZARIDIS KN.Primary biliary cholangitis, DNA, and beyond:The Relative contribution of genes[J].Hepatology, 2018, 68 (1) :19-21.
|
|
[6]RODRIGUES PM, PERUGORRIA MJ, SANTOS-LASO A, et al.Primary biliary cholangitis:A tale of epigenetically-induced secretory failure?[J].J Hepatol, 2018, 69 (6) :1371-1383.
|
|
[7]WANG L, HAN Y.An excerpt of primary biliary cholangitis:2018 practice guidance from the American Association for the Study of Liver Diseases[J].J Clin Hepatol, 2018, 34 (11) :2300-2304. (in Chinese) 王璐, 韩英.《2018年美国肝病学会原发性胆汁性胆管炎实践指导》摘译[J].临床肝胆病杂志, 2018, 34 (11) :2300-2304.
|
|
[8]WANG QX, MA X.Primary biliary cholangitis:Opportunities and challenges[J].J Clin Hepatol, 2017, 33 (11) :2049-2051. (in Chinese) 王绮夏, 马雄.原发性胆汁性胆管炎:机遇与挑战[J].临床肝胆病杂志, 2017, 33 (11) :2049-2051.
|
|
[9]OLAIZOLA P, LEE-LAW PY, ARBELAIZ A, et al.MicroRNAs and extracellular vesicles in cholangiopathies[J].Biochim Biophys Acta Mol Basis Dis, 2018, 1864 (4 Pt B) :1293-1307.
|
|
[10]DYSON JK, HIRSCHFIELD GM, ADAMS DH, et al.Novel therapeutic targets in primary biliary cirrhosis[J].Nat Rev Gastroenterol Hepatol, 2015, 12 (3) :147-158.
|
|
[11]PARES A, CABALLERIA L, RODES J.Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid[J].Gastroenterology, 2006, 130 (3) :715-720.
|
|
[12]HIRSCHFIELD GM, MASON A, LUKETIC V, et al.Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid[J].Gastroenterology, 2015, 148 (4) :751-761, e8.
|
|
[13]SZABO G, BALA S.MicroRNAs in liver disease[J].Nat Rev Gastroenterol Hepatol, 2013, 10 (9) :542-552.
|
|
[14]ESPARZA-BAQUER A, LABIANO I, BUJANDA L, et al.MicroRNAs in cholangiopathies:Potential diagnostic and therapeutic tools[J].Clin Res Hepatol Gastroenterol, 2016, 40 (1) :15-27.
|
|
[15]TAN Y, PAN T, YE Y, et al.Serum microRNAs as potential biomarkers of primary biliary cirrhosis[J].PLo S One, 2014, 9 (10) :e111424.
|
|
[16]PADGETT KA, LAN RY, LEUNG PC, et al.Primary biliary cirrhosis is associated with altered hepatic microRNA expression[J].J Autoimmun, 2009, 32 (3-4) :246-253.
|
|
[17]QIN B, HUANG F, LIANG Y, et al.Analysis of altered microR-NA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis[J].J Gastroenterol Hepatol, 2013, 28 (3) :543-550.
|
|
[18]BANALES JM, SAEZ E, URIZ M, et al.Up-regulation of microRNA 506 leads to decreased Cl-/HCO3-anion exchanger2 expression in biliary epithelium of patients with primary biliary cirrhosis[J].Hepatology, 2012, 56 (2) :687-697.
|
|
[19]XIE YQ, MA HD, LIAN ZX.Epigenetics and Primary Biliary Cirrhosis:A comprehensive review and implications for autoimmunity[J].Clin Rev Al ergy Immunol, 2016, 50 (3) :390-403.
|
|
[20]ERICE O, MUNOZ-GARRIDO P, VAQUERO J, et al.MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation[J].Hepatology, 2018, 67 (4) :1420-1440.
|
|
[21]ANANTHANARAYANAN M, BANALES JM, GUERRA MT, et al.Post-translational regulation of the type III inositol 1, 4, 5-trisphosphate receptor by miRNA-506[J].J Biol Chem, 2015, 290 (1) :184-196.
|
|
[22]KATSUMI T, NINOMIYA M, NISHINA T, et al.MiR-139-5p is associated with inflammatory regulation through c-FOSsuppression, and contributes to the progression of primary biliary cholangitis[J].Lab Invest, 2016, 96 (11) :1165-1177.
|
|
[23]KEMPINSKA-PODHORODECKA A, MILKIEWICZ M, WASIK U, et al.Decreased expression of vitamin D receptor affects an immune response in primary biliary cholangitis via the VDR-miR-NA155-SOCS1 pathway[J].Int J Mol Sci, 2017, 18 (2) :E289.
|
|
[24]WASIK U, MILKIEWICZ M, KEMPINSKA-PODHORODECKAA, et al.Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in primary biliary cholangitis[J].Sci Rep, 2017, 7:44769.
|
|
[25]WANG X, WEN X, ZHOU J, et al.MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients[J].PLo S One, 2017, 12 (9) :e0184292.
|
|
[26]NAKAGAWA R, MUROYAMA R, SAEKI C, et al.miR-425regulates inflammatory cytokine production in CD4 (+) T cells via N-Ras upregulation in primary biliary cholangitis[J].JHepatol, 2017, 66 (6) :1223-1230.
|
|
[27] QIAN Z, CHEN SX, REN CL, et al.Abnormal expression of miR-let-7b in primary biliary cirrhosis and its clinical significance[J].Chin J Hepatol, 2013, 21 (7) :533-536. (in Chinese) 钱琤, 陈孙孝, 任传路, 等.原发性胆汁性肝硬化患者miR-let-7b的异常表达及其意义[J].中华肝脏病杂志, 2013, 21 (7) :533-536.
|
|
[28]KATSUSHIMA F, TAKAHASHI A, SAKAMOTO N, et al.Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients[J].Hepatol Res, 2014, 44 (10) :e189-e197.
|
|
[29]TOMIYAMA T, YANG G X, ZHAO M, et al.The modulation of costimulatory molecules by circulating exosomes in primary biliary cirrhosis[J].Cell Mol Immunol, 2017, 14 (3) :276-284.
|
|
[30]LIANG DY, HOU YQ, LUO LJ, et al.Altered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosis[J].Int J Mol Med, 2016, 38 (1) :131-138.
|
|
[31]YAMAURA Y, TATSUMI N, TAKAGI S, et al.Serum microRNAprofiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury[J].Clin Biochem, 2017, 50 (18) :1034-1039.
|
|
[32]SAKAMOTO T, MORISHITA A, NOMURA T, et al.Identification of microRNA profiles associated with refractory primary biliary cirrhosis[J].Mol Med Rep, 2016, 14 (4) :3350-3356.
|
|
[33]NINOMIYA M, KONDO Y, FUNAYAMA R, et al.Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers[J].PLo S One, 2013, 8 (6) :e66086.
|
|
[34]AIBA Y, NAKAMURA M, JOSHITA S, et al.Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients[J].J Gastroenterol, 2011, 46 (10) :1203-1212.
|
|
[35]SALAS JT, BANALES JM, SARVIDE S, et al.Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis[J].Gastroenterology, 2008, 134 (5) :1482-1493.
|
|
[36]MINAGAWA N, NAGATA J, SHIBAO K, et al.Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile[J].Gastroenterology, 2007, 133 (5) :1592-1602.
|
|
[37]SHIBAO K, HIRATA K, ROBERT ME, et al.Loss of inositol 1, 4, 5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis[J].Gastroenterology, 2003, 125 (4) :1175-1187.
|
|
[38]YE D, ZHANG T, LOU G, et al.Role of miR-223 in the pathophysiology of liver diseases[J].Exp Mol Med, 2018, 50 (9) :128.
|
|
[39]AFONSO MB, RODRIGUES PM, SIMAO AL, et al.miRNA-21 ablation protects against liver injury and necroptosis in cholestasis[J].Cell Death Differ, 2018, 25 (5) :857-872.
|
|
[40]KAMEL RR, AMR KS, AFIFY M, et al.Relation between microRNAs and apoptosis in hepatocellular carcinoma[J].Open Access Maced J Med Sci, 2016, 4 (1) :31-37.
|
|
[41]FIORINO S, BACCHI-REGGIANI ML, VISANI M, et al.MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B-and C-related-hepatocellular-carcinoma[J].World J Gastroenterol, 2016, 22 (15) :3907-3936.
|
|
[42]GATSELIS NK, DALEKOS GN.Molecular diagnostic testing for primary biliary cholangitis[J].Expert Rev Mol Diagn, 2016, 16 (9) :1001-1010.
|
|
[43]MCDANIEL K, HALL C, SATO K, et al.Lin28 and let-7:Roles and regulation in liver diseases[J].Am J Physiol Gastrointest Liver Physiol, 2016, 310 (10) :g757-g765.
|
|
[44]SATO K, MENG F, GLASER S, et al.Exosomes in liver pathology[J].J Hepatol, 2016, 65 (1) :213-221.
|
|
[45]QIN LX, SUN HT, WANG CQ.Application of the exosome in diagnosis and treatment of digestive system cancers[J].Chin J Dig Surg, 2018, 17 (4) :333-337. (in Chinese) 钦伦秀, 孙豪庭, 王超群.外泌体在消化系统肿瘤精准诊断与治疗中的应用[J].中华消化外科杂志, 2018, 17 (4) :333-337.
|
DownLoad: